This study is an interventional clinical trial, in order to determine and implement the best techniques for hemostasis in patients with endometrioma cystectomy that surgery necessity is diagnosed for them. Inclusion criteria for our study are patients aged 18-42 years, regular menstrual cycles with ovarian endometrioma, complaining of dysmenorrhea, infertility or pelvic mass for whom surgery is considered necessary. Exclusion criteria is also a history of ovarian surgery, pelvic inflammatory disease, previous chemotherapy or endocrine diseases (such as diabetes or hyper prolactinoma). Anti-Mullerian hormone levels, estradiol and FSH on the third day of the menstrual cycle before surgery are measured.
The laparoscopic cystectomy performed on patients using atromatic graspers then hemostasis with bipolar electrocoagulation or suturing technique, randomly was done by a surgeon. The number of calculated samples in each group is 44. Again 3 months after surgery, the laboratory tests on the third day of the menstrual cycle will be measured. The post operative results of anti-Mullerian hormone, estradiol, and FSH with preoperative values in both groups (surgical hemostasis with bipolar and suturing) and also between the two groups will be compared. Then, these comparisons should be interpreted.